Skip to main content
. 2021 Mar 25;21:144. doi: 10.1186/s12887-021-02614-2

Table 4.

The underlying diseases among the studied cases

Studied variables Number (%)
No underlying diseases 305 76.6%
Underlying diseases 93 23.4%
• Epilepsy 23 5.8%
*ITP 20 5.0%
• Chronic kidney disease 20 5.0%
• Neurodegenerative disease 7 1.8%
• Arnold Chiari syndrome 7 1.8%
• Guillain barre syndrome 6 1.5%
*G6PD 5 1.25%
• Beta thalassemia 3 0.75%
• Dyskeratosis congenita 2 0.5%

ITP Immune thrombocytopenic purpura, G6PD Glucose 6 phosphate dehydrogenase deficiency